Background. Fluoroquinolones (FQ) have the potential for serious side effects such as tendonitis and tendon rupture, QTc prolongation, severe neuropathies, Clostridium difficile infection, dysglycemia, and AKI in patients on ACE inhibitors or ARBs. Beginning in 2016, the University of Chicago Medicine (UCM) Antibiotics Stewardship Program began to give targeted feedback and education to outpatient clinic areas regarding their FQ use to reduce the number of prescriptions.
Methods. Outpatient FQ prescribing data from July 2015 to June 2016 (pre-intervention) and December 2016 to December 2017 (post-intervention) was reviewed retrospectively to evaluate indications, durations and alternatives for FQ prescriptions. Education and targeted feedback specific to the clinical area on current FQ usage was given by peer-comparison or aggregate data with recommendations for improved prescribing practices. The number of ciprofloxacin prescriptions/1,000 clinic visits was evaluated in two outpatient clinics and number of ciprofloxacin prescriptions/1,000 patient discharges was evaluated in the emergency department pre and post intervention. FQ use in the two time periods was compared using the unpaired T-test.
Results. Ciprofloxacin use in the primary care group (PCG) (12.9%), student care (SC) (7.1%), and emergency department (ED) (8.6%) accounted for 28.6% of overall Ciprofloxacin use in the pre-intervention time period. A significant decrease in ciprofloxacin prescribing was seen in the PCG, 8.78Rx/1,000 patient visits (PRE) vs. 5.24Rx/1,000 patient visits (POST), P < 0.001; in SC, 16.25 Rx/1,000 patient visits (PRE) vs. 6.76Rx/1,000 patient visits (POST), P < 0.001; and the ED, 13.37RX/1,000 patient discharges (PRE) vs. 9.84/1,000 patient discharges (POST) (P = 0.035). Peer comparison data were well received by PCG faculty. Decreases have been sustained in each clinical area 4 (ED) to 12 months (PCG and student care) following the intervention.
Conclusion. Feedback on both aggregate clinic and individual use of ciprofloxacin resulted in decrease use in three outpatient clinical areas at UCM and was well received by providers. Further work is up needed to assess the most effective methods to optimize antibiotic prescribing in the ambulatory clinics.
Disclosures. Background. Fluoroquinolone (FQ) use is associated with the development of C. difficile colitis, emergence of multidrug-resistant pathogens and occurrence of multiple adverse effects. In light of these risks, the Food and Drug Administration (FDA) warns against the overuse of systemic FQs for certain infections. Utilization of clinical decision support systems or alert tools integrated within the computerized physician order entry (CPOE) have been implemented in the inpatient setting to reduce antibiotic use. However, there is limited data on the effectiveness of such strategies in the outpatient setting. The purpose of this study was to evaluate the impact of an antimicrobial stewardship initiative on FQ utilization in the outpatient setting.
Methods. This was a retrospective chart review of patients ≥18 years old who received a FQ upon discharge from the inpatient setting, emergency department or outpatient clinics at a large academic medical center. The intervention consisted of an automatic electronic alert that would appear upon prescribing of a FQ, suggesting use of an alternative antibiotic and requiring a diagnosis to be entered. The pre and post intervention periods spanned from November 16, 2016 to April 16, 2017 and from November 16, 2017 to April 16, 2018 , respectively. The primary endpoint was the number of FQ prescriptions over the total number of visits in the pre-and post-intervention time periods. A secondary endpoint was days of therapy (DOT) on an FQ.
Results. 1,668 patients received FQs upon discharge in the pre-intervention arm and 1,494 in the post-intervention arm. Compared with the pre-intervention group, fewer FQs were prescribed in the post intervention group (P = 0.002). Fewer patients were discharged on an FQ from the outpatient clinics in the post-intervention arm compared with the pre-intervention arm (31 vs. 39%). However, this did not hold true when evaluating the number of FQ prescriptions written from the inpatient setting (52% in the post and 42% in the pre-intervention). DOT was lower in the post-intervention arm (10,751.5) compared with the pre-intervention period (11, 961) .
Conclusion. Implementation of a mandatory electronic alert tool in CPOE showed a statistically significant reduction in the overall number of FQ prescriptions between the pre and post intervention groups in the outpatient setting.
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